ScholarIQanswers from OpenAlex & ORCID
Tomohide Tamura
ResearcherPublications, citations & collaboration network
Tomohide Tamura is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Tomohide Tamura have?
ScholarIQindexed works
Tomohide Tamura has 518 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Tomohide Tamura have?
ScholarIQcitation count
Tomohide Tamura has 21,850 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Tomohide Tamura?
ScholarIQh-index
Tomohide Tamura has an h-index of 68 in OpenAlex.
What is the i10-index of Tomohide Tamura?
ScholarIQi10-index
Tomohide Tamura has an i10-index of 251 in OpenAlex.
What is the ORCID of Tomohide Tamura?
ScholarIQorcid
The ORCID for Tomohide Tamura is on the source record.
What is the OpenAlex record for Tomohide Tamura?
ScholarIQopenalex
The OpenAlex for Tomohide Tamura is on the source record.
What are the most-cited papers on Tomohide Tamura?
ScholarIQmost cited works
Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
Toyoaki Hida, Hiroshi Nokihara, Masashi Kondo, Young Hak Kim, Koichi Azuma, Takashi Seto, Yuichi Takiguchi, Makoto Nishio, Hiroshige Yoshioka, Fumio Imamura, Katsuyuki Hotta, Satoshi Watanabe, Kōichi Goto, Miyako Satouchi, Toshiyuki Kozuki, Takehito Shukuya, Kazuhiko Nakagawa, Tetsuya Mitsudomi, Nobuyuki Yamamoto, T. Asakawa, Ryoichi Asabe, Tomohiro Tanaka, Tomohide Tamura
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
Yuichiro Ohe, Yasuo Ohashi, Kaoru Kubota, Tomohide Tamura, Kazuhiko Nakagawa, Shunichi Negoro, Yutaka Nishiwaki, Nagahiro Saijo, Y Ariyoshi, M. Fukuoka
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study
Takashi Seto, Katsuyuki Kiura, Makoto Nishio, Kazuhiko Nakagawa, Makoto Maemondo, Akira Inoue, Toyoaki Hida, Nobuyuki Yamamoto, Hiroshige Yoshioka, Masao Harada, Yuichiro Ohe, Naoyuki Nogami, Kengo Takeuchi, Tadashi Shimada, Tomohiro Tanaka, Tomohide Tamura
Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
Antônio Rossi, Massimo Di Maïo, Paolo Chiodini, Robin Rudd, Hiroaki Okamoto, Dimosthenis Skarlos, Martin Früh, Wendi Qian, Tomohide Tamura, E. Samantas, Taro Shibata, Francesco Perrone, Ciro Gallo, Cesare Gridelli, Olga Martelli, Siow Ming Lee
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer
Ramaswamy Govindan, Aleksandra Szczęsna, Myung‐Ju Ahn, Claus-Peter Schneider, Pablo Fernando Gonzalez Mella, Fabrice Barlési, Baohui Han, Doina Ganea, Joachim von Pawel, Vladimir Vladimirov, Natalia Fadeeva, Ki Hyeong Lee, Takayasu Kurata, Li Zhang, Tomohide Tamura, Pieter E. Postmus, Jacek Jassem, Kenneth J. O’Byrne, Justin Kopit, Mingshun Li, Marina Tschaika, Martin Reck